Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
Open accessPublished version of a preprint
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
To the Editor—The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in places where the virus is uncontained poses a global threat from the perspective of public health and vaccine efficacy. Peng et al [1] recently reported on the increased transmissibility with the newly emerged Variant of Concern (VOC) (20C/S:452R and 20C/S:452R) with the L452R mutation in San Francisco. We report the immunological characteristics of a Variant under Investigation (VUI) B.1.617.1, playing a critical role in the current surge of coronavirus disease 2019 (COVID-19) in the western state of Maharashtra, India. Several SARS-CoV-2 variants—B.1.1.7, B.1.351, and B.1.1.28.1—have been reported in India during 2021 [2, 3]. We had sequenced 146 nasopharyngeal/oropharyngeal swabs of COVID-19 cases [4]. Among these, 15 sequences had a combination of L452R and E484Q mutations, which raised concern as both are found in the receptor-binding domain (RBD) of the spike protein. However, the combined effect of these mutations is still unknown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.012 · Cited by 1,956
Neutralizing Activity of BNT162b2-Elicited Serum
Liu, Y., Liu, J., Xia, H., Zhang, X., Fontes-Garfias, C. R., Swanson, K. A., Cai, H., Sarkar, R., Chen, W., Cutler, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2102017 · Cited by 537
Ella, R., Vadrevu, K. M., Jogdand, H., Prasad, S., Reddy, S., Sarangi, V., Ganneru, B., Sapkal, G., Yadav, P., Abraham, P., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30942-7 · Cited by 424
Self-citationTchesnokova, V., Kulasekara, H., Larson, L., Bowers, V., Rechkina, E., Kisiela, D., Sledneva, Y., Choudhury, D., Maslova, I., Deng, K., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00921-21 · Cited by 217
Tchesnokova, V., Kulakesara, H., Larson, L., et al. (2021) · bioRxiv · doi:10.1101/2021.02.22.432189 · Cited by 154
Teng, S., Sobitan, A., Rhoades, R. E., Liu, D., & Tang, Q. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa233 · Cited by 125
Sapkal, G. N., Yadav, P. D., Ella, R., Deshpande, G. R., Sahay, R. R., Gupta, N., Vadrevu, K. M., Abraham, P., Panda, S., & Bhargava, B. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab051 · Cited by 121
Self-citationFirst isolation of SARS-CoV-2 from clinical samples in India
Sarkale, P., Patil, S., Yadav, P. D., Nyayanit, D. A., Sapkal, G. N., Baradkar, S., Lakra, R., Shete-Aich, A., Prasad, S., Basu, A., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1029_20 · Cited by 112
Self-citationNeutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
Deshpande, G. R., Sapkal, G. N., Tilekar, B. N., Yadav, P. D., Gurav, Y. K., Gaikwad, S., Kaushal, H., Deshpande, K., Kaduskar, O., Sarkale, P., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2382_20 · Cited by 77
Self-citationYadav, P. D., Nyayanit, D. A., Sahay, R. R., Sarkale, P., Pethani, J. D., Patil, S., Baradkar, S., Potdar, V. A., & Patil, D. Y. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab009 · Cited by 45
Self-citationPeng, J., Liu, J., Mann, S. A., Mitchell, A. M., Laurie, M. T., Sunshine, S., Pilarowski, G., Ayscue, P., Kistler, A., Vanaerschot, M., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab283 · Cited by 41
Yadav, P. D., Nyayanit, D. A., Shete, A. M., Jain, S., Majumdar, T., Chaubal, G. Y., Shil, P., Kore, P., & Mourya, D. T. (2018) · Ticks and Tick-borne Diseases · doi:10.1016/j.ttbdis.2018.08.012 · Cited by 40
Self-citationNon-human primate and human malaria: past, present and future
Antinori, S., Bonazzetti, C., Giacomelli, A., Corbellino, M., Galli, M., Parravicini, C., & Ridolfo, A. L. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab036 · Cited by 36
Peng, J., Mann, S., Mitchell, A. M., et al. (2021) · medRxiv · doi:10.1101/2021.03.01.21252705 · Cited by 24
Research works printed but not linked: 1
- Rambaut, Nat Microbiol
Cited by
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108891 · Cited by 2,889
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Planas, D., Veyer, D., Baidaliuk, A., Staropoli, I., Guivel-Benhassine, F., Rajah, M. M., Planchais, C., Porrot, F., Robillard, N., Puech, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03777-9 · Cited by 1,992
Fiolet, T., Kherabi, Y., MacDonald, C.-J., Ghosn, J., & Peiffer-Smadja, N. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.005 · Cited by 911
Cherian, S., Potdar, V., Jadhav, S., Yadav, P., Gupta, N., Das, M., Rakshit, P., Singh, S., Abraham, P., Panda, S., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9071542 · Cited by 730
Self-citationStructural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Yuan, M., Huang, D., Lee, C.-C. D., Wu, N. C., Jackson, A. M., Zhu, X., Liu, H., Peng, L., van Gils, M. J., Sanders, R. W., et al. (2021) · doi:10.1101/2021.02.16.430500 · Cited by 364
Metadata
- Authors
- Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K.
- Affiliations
- ICMR-National Institute of Virology (IN)
- Bharat Biotech (India) (IN)
- Indian Council of Medical Research (IN)
- Corresponding author
- Yadav, Pragya D
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-05-07
- Volume
- 74
- Issue
- 2
- Pages
- 366-368
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3159365602
- Cited by
- 251
- References
- 14
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 10 · 2023: 26 · 2022: 76 · 2021: 133
- FWCI
- 19.38
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Clinical Infectious Diseases (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Indian Council of Medical Research
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- SARS-CoV-2, Omicron variant, L452R mutation, receptor binding domain, Maharashtra, COVID-19 pandemic, spike protein mutations
- MeSH terms
- Antibodies, Viral, Humans, Neutralization Tests, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.